TLDR  COVID-19 may be linked to hair loss or worsening of hair loss in some people.   
  This systematic review analyzed 9 studies out of 402 articles, investigating the link between COVID-19 and alopecia areata, an autoimmune disease causing hair loss. The review found 7 new cases of alopecia areata following confirmed SARS-CoV-2 infection and instances of alopecia areata recurrence or exacerbation in patients with preexisting disease after SARS-CoV-2 infection. The findings suggest that alopecia areata may be a dermatologic manifestation of COVID-19, often appearing 1 to 2 months following infection. However, due to the heterogeneity of the studies and a high proportion of case reports, definitive conclusions cannot be drawn. The review also highlighted the potential exacerbating effects of physical and psychosocial stress on alopecia areata. Further research is needed to better understand the relationship between alopecia areata and COVID-19.
            11 citations
,
  May 2021   in “Journal of The American Academy of Dermatology”
           11 citations
,
  May 2021   in “Journal of The American Academy of Dermatology”    COVID-19 doesn't make alopecia areata worse.  
      32 citations
,
  March 2021   in “Journal of cosmetic dermatology (Print)”
           32 citations
,
  March 2021   in “Journal of cosmetic dermatology (Print)”    COVID-19 infection may trigger alopecia areata in some patients.  
      10 citations
,
  March 2021   in “Skin health and disease”
           10 citations
,
  March 2021   in “Skin health and disease”    COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.  
      14 citations
,
  February 2021   in “Journal of the European Academy of Dermatology and Venereology”
           14 citations
,
  February 2021   in “Journal of the European Academy of Dermatology and Venereology”    A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.  
               51 citations
,
  December 2017   in “Skin Appendage Disorders”    Stress may trigger hair loss by affecting immune protection in hair follicles.  
    
  
        
      5 citations
,
  January 2022   in “Dermatology Reports”
           5 citations
,
  January 2022   in “Dermatology Reports”    Tofacitinib treatment for hair loss may worsen acne.  
      October 2021   in “Dermatology Reports”
           October 2021   in “Dermatology Reports”    Tofacitinib, a hair regrowth treatment, may worsen acne.  
      April 2019   in “International journal of research in dermatology”
           April 2019   in “International journal of research in dermatology”    A child with rough nails also had hair loss and allergies.  
      37 citations
,
  October 2017   in “Clinical and Experimental Dermatology”
           37 citations
,
  October 2017   in “Clinical and Experimental Dermatology”    Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.  
               18 citations
,
  January 2010   in “Dermatology Research and Practice”    DPCP treatment for alopecia areata can sometimes cause vitiligo.